COMMUNIQUÉS West-GlobeNewswire

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
06/05/2026
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
OraSure Announces First Quarter 2026 Financial Results
06/05/2026
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for [...]
Pennant Reports First Quarter 2026 Results
06/05/2026
Conference Call and Webcast scheduled for tomorrow, May 7, 2026 at 10:00 am MT EAGLE, Idaho, May 06, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated [...]
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
06/05/2026
MIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced plans to present [...]
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
06/05/2026
Daraxonrasib demonstrated unprecedented survival benefit in Phase 3 RASolute 302 trial in previously treated metastatic pancreatic cancer; detailed results will be presented in upcoming ASCO Plenary presentation [...]
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
06/05/2026
Leadership transition marks next evolution of growth May 6, 2026 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovator committed to improving the lives of people suffering [...]
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
06/05/2026
Galapagos’ name change to Lakefront Biotherapeutics approved at the Company’s EGM (Euronext & NASDAQ: LKFT) Collaboration Agreement with Gilead to advance potential First and Best-in-Class T Cell Engager expected to [...]
BridgeBio to Participate in May and June Investor Conferences
06/05/2026
PALO ALTO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
06/05/2026
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2026, the Company [...]
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
06/05/2026
Company to host conference call to discuss financial results and provide a corporate update on May 13, 2026 at 4:30 p.m. ET SCOTTSDALE, Ariz., May 06, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey [...]
New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years
06/05/2026
COPENHAGEN, Denmark, May 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from a subgroup analysis showing that children with achondroplasia ≥5 years of age at enrollment treated [...]
MannKind Reports First Quarter 2026 Financial Results and Provides Business Update
06/05/2026
Q1 updates: Q1 2026 total revenues of $90.2M, +15% vs. Q1 2025 Built out launch infrastructure and aligned field-based teams for upcoming launches Settlement of senior convertible notes of $36.3M Program updates: [...]
Teknova Reports First Quarter 2026 Financial Results
06/05/2026
First quarter 2026 total revenue was $11.1 million, up 13% over the same quarter prior year Company reaffirms 2026 revenue guidance of $42-44 million HOLLISTER, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, [...]
Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update
06/05/2026
Q1 2026 net product revenue for ZORYVE ® (roflumilast) was $105.4 million, a 65% increase compared to Q1 2025, and a 17% decrease compared to Q4 2025 Continued strong demand for ZORYVE despite typical Q1 seasonality, [...]
Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk
06/05/2026
MOUNTAIN VIEW, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Diathrive Health, the leader in chronic disease management, and AliveCor, the global leader in AI-powered cardiology, today announced a strategic partnership to [...]
Growth in revenue and operating profit
06/05/2026
Trading statement for Q3 2025/26 (1 January – 31 March 2026) Growth in revenue and operating profit ChemoMetec’s revenue was up by 15% in the third quarter of 2025/26 to DKK 142.3 million from DKK 124.2 million in the [...]
Renewa Micro-Infusion System Claims Evaluated: The Painless Skin Microneedling Device for At-Home Face Lift Treatment
06/05/2026
How the Renewa Skin 0.3mm Gold-Needle Micro-Infusion Device Is Designed for Fine Lines, Skin Firmness, and At-Home Cosmetic Skincare for Women Over 50 in 2026 Sheridan, WY, May 06, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Interim Report Q1 2026: Navigating challenging markets in EMEA and taking actions to adjust the cost structure for future healthy margins
06/05/2026
Highlights Following the announcement of GN Store Nord’s divestment of its Hearing division, the financial performance related hereto is treated as discontinued operations in the Q1 2026 report and until closing of the [...]
Guidance updated to reflect Hearing business being treated as discontinued operations
06/05/2026
Following the company announcement on March 16, 2026 (“GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion”), GN is now reintroducing a profitability guidance for [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum